PATENT CLAIM ANALYSIS

Application Number: 15760697
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["424", "172100"]

Abstract:
Provided is a compound having formula (I): wherein R 2  is selected from —C 1 , —Br and —CN; R 1  and R 4  are independently selected from H and —F; R 631 , R 632 , R 641  and R 642  are independently selected from —H, —F and substituted or unsubstituted C 1 -C 3  alkyl groups; and R 651  and R 652  are independently selected from H and substituted or unsubstituted C 1 -C 3  alkyl groups and substituted or unsubstituted phenyl groups; and wherein at least one of R 631 , R 632 , R 641 , R 642  and R 652  is not —H, or wherein when all of R 631 , R 632 , R 641 , R 642  and R 652  are —H, R 651  is not Me or Et.

Claim (Index 31):
The method according to  claim 30  for treating a cancer, which method comprises administering to a patient a compound or a composition of  claim 1  and a further agent for treating a cancer as defined in  claim 27 ; wherein the compound and the further agent are administered simultaneously, sequentially or separately.

Metadata:
- Claim Count in Document: 18.0
- Percentile: 90.0
- Lexical Diversity: 2.77358
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15504703', '15100494', '15105615', '15524142', '15301619']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7839244759212443
- 35 USC 102 Novelty (BERT): 0.5350986149264487
- Combined Prediction Score: 0.7590418898217648
- Mean Citation Score: 355.36224
- Max Citation Score: 374.16812
- Similarity Product: 197.6076900296736

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test